acetylglucosamine has been researched along with Diffuse Large B-Cell Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryant, JL; Chen, J; Ford, RJ; Manyam, GC; Medeiros, LJ; Mendez, R; Pham, LV; Tamayo, AT; Xu-Monette, ZY; Yang, D; Young, KH | 1 |
| Chou, TH; Kessel, D; Khilanani, P; Ratanatharathorn, V | 1 |
2 other study(ies) available for acetylglucosamine and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.
Topics: Acetylglucosamine; Animals; Antineoplastic Agents; Apoptosis; Azaserine; Cell Line, Tumor; Cell Proliferation; Contrast Media; Cysteine; Enzyme Inhibitors; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glycosylation; Hexosamines; Humans; Lymphoma, Large B-Cell, Diffuse; Mice, Inbred NOD; Mice, SCID; N-Acetylglucosaminyltransferases; NF-kappa B; NFATC Transcription Factors; Organotechnetium Compounds; RNA Interference; RNA, Messenger; RNAi Therapeutics; Signal Transduction; Transfection | 2016 |
Evaluation of two plasma fucosyltransferases as marker enzymes in non-Hodgkin's lymphoma.
Topics: Acetylglucosamine; Adult; Aged; Antineoplastic Agents; Female; Galactosides; Guanosine Diphosphate Fucose; Hexosyltransferases; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Remission, Spontaneous | 1978 |